Landon Sims

MCIP PhD Candidate @ucdavis. Nutrient sensing + neuroendocrine control of behavior & metabolism.

[Ross P. Wohlgemuth, Ph.D. @rpwohlgemuth]

It has been in the works for a while, but I finally published the research I worked on as an undergraduate @CalPoly in @CompBiochPhys. Thankful for the continuous mentorship I have received throughout this process. Read about my "supercool" lizards here: https://t.co/iD5zBFx6EX

[MCIP at UC Davis @MCIPUCD]

Big day today for #MCIP, we have our Recruitment Day 🎉 we are hosting 14 amazing prospective students. Stay tune for the day activities. Here we go!

[Landon Sims @landoncsims]

@maria_chond @IMS_MRL Congratulations!!

[SEC Network @SECNetwork]

TWO-POINT CONVERSION
IN OVERTIME
FOR THE WIN
IN DEATH VALLEY
🔥🔥🔥🔥🔥🔥
@LSUFootball

[Suraj J. Pathak @surajjpathak]

Excited to share my first, first author paper out in @ESSRonline. To say I'm grateful doesn't even begin to describe it. To everyone that deals or has dealt with me on a daily basis, you're the real GOAT. https://t.co/nsVla77Eys

[Xianfeng Zeng @xianfeng_zeng]

Excited to share our work online at @CellCellPress today. Isotope tracing into bacterial-specific protein sequences tells what nutrient different microbes prefer in the gut. Huge thanks to Josh, @cholsoon_jang, @MartinWuhr, @donia_lab for the guidance. https://t.co/CkUvR4pW9s

[Manuel F. Navedo @mf_navedo]

Want to know why the heartbeat is altered during heart failure? We found that this is in part due to the disruption of mitochondria–sarcoplasmic reticulum microdomain connectomics in SAN cells. Out now in @PNASNews!

https://t.co/nw27XYEbBK

[Landon Sims @landoncsims]

@CharlesMBrenner Not sure about astros, but if the cDNA synth is accurate (& clean) CyclophilinA is nice b/t peripheral cell types. If not, I look at TBP & Rps18 first before alts. RE of target(s) always 1st thought - I favor *modest* to low ubq expression ref vs. targets

[Ross P. Wohlgemuth, Ph.D. @rpwohlgemuth]

Our preprint of the effects of a collagen cross-link inhibitor on dystrophic skeletal muscle is out on bioRxiv. Happy to be co-first author with @sarah_brash25 in @MyoMatrix lab!

[Giuseppe Gangarossa 🧠🧑‍🔬🇪🇺🏳️‍🌈 @PeppeGanga]

HAPPY 🍾🥳🤩 to share our article published in @JPhysiol. Many congrats to 1st author Clarisse Dumont! @Univ_Paris

Hindbrain catecholaminergic inputs to the paraventricular thalamus scale feeding and metabolic efficiency in stress‐related contexts https://t.co/VBkVSWMM8y

[Marcus Goncalves @MarcusDGon]

Now online ⁦@NatureRevCancer⁩ Our latest thoughts on a rapidly advancing field. Which diet for which tumor? What diet-drug combinations do we have? How can we make our trials more robust? ⁦@SamwiseT⁩ ⁦@CantleyLab⁩ @notwitterFalcone https://t.co/HDrHGRDQCG

[American Aging Association @americanaging]

Our final speaker for the Trainee Chapter Symposium is Robert Newton discussing Lifestyle Interventions targeting dementia risk factors in ethnic/ racial minorities

[Lamming Lab @LammingLab]

Still looking for a new team member - apply today!

[Philip Schauer, MD @PSchauerMD]

Claude Bouchard PhD, luminary scientist, retires from Pennington Biomedical. He led PBRC through a tremendous period of growth and prosperity. Congrats Claude, thanks for your leadership! @PBRCNews @DrJohnKirwan @DrLeanneRedman @metabolic_knife @DonnaRyanMD @schutte_rebecca

[Landon Sims @landoncsims]

Gut microbiome is increasingly implicated in disease. Dietary intervention can *help* in a broad sense, but we need better (1) tools to quantify existing spp. and metabolites, and (2) specific targets for modulation of gut-organ (of many) crosstalk. #DEB263

[Cell Metabolism @Cell_Metabolism]

This Perspective discussed our understanding of the gut-liver axis in nonalcoholic fatty liver disease (NAFLD)
https://t.co/sfvHtPw0VL

#openaccess #1YearAgo @DrLoomba @KnightLabNews

[Landon Sims @landoncsims]

Interesting find - therapeutics for age-related neurodegeneration with frontal lobe implicated might benefit from a combinatorial approach w/ MetR. #DEB263

[IDIAPJGol @IDIAPJGol]

Age-Related Changes in Lipidome of Rat Frontal Cortex and Cerebellum Are Partially Reversed by Methionine Restriction Applied in Old Age
https://t.co/pCcx9eDx4C

[Landon Sims @landoncsims]

Important to highlight that the TAME study will be the first multi-year clinical trial to assess “anti-aging” (improved chronic disease status) effects of metformin. We need FDA to green-light more geroscience clin. trials to get breakthrough therapies to market. #DEB263

[Longevity Technology @LongevityTech]

Kitalys Institute: breaking down the barriers to longevity clinical trials.
@KitalysI's founder calls for regulatory changes to allow #geroscience innovation to flourish and enable true #longevity trials.
#biotech #aging @metabesity @NirBarzilaiMD
https://t.co/z0s3tD6pZ1